Skip to main content

Table 1 Baseline ambulance and hospital admission characteristics of Mimic patients enrolled in the RIGHT-2 trial. Data are number (%), median [IQR], or mean (standard deviation)

From: Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial

 

All

GTN

Sham

Difference

2p

Ambulance data (pre-randomisation)

 Number of patients

297

134

163

 

 Age (years)

67 (18)

68 (19)

66 (18)

1.7 (− 2.4, 5.9)

0.41

  < 60 (%)

107 (36)

49 (37)

58 (36)

 

 60–70 (%)

45 (15)

17 (13)

28 (17)

 70–80 (%)

55 (19)

22 (16)

33 (20)

  ≥ 80 (%)

90 (30)

46 (34)

44 (27)

 Sex (female) (%)

157 (53)

74 (55)

83 (51)

4.3 (−7.1, 15.7)

0.46

 Time from onset to randomisation (minutes)

75 [47,126]

72.5 [48,120]

79 [46,140]

−6.0 (−19.0, 5.0)

0.27

 ECG, AF/flutter (%)

29 (13)

11 (11)

18 (15)

3.6 (−5.1, 12.3)

0.42

 Systolic blood pressure (mmHg)

159 (26)

155 (24)

162 (27)

−7.0 (−12.9, − 1.1)

0.021

 Diastolic blood pressure (mmHg)

91 (16)

89 (16)

92 (16)

−2.7 (−6.4, 1.0)

0.15

 Heart rate (bpm)

83 (19)

82 (16)

84 (21)

−1.7 (−5.9, 2.6)

0.44

 Glasgow coma scale

14 (2)

14 (2)

14 (2)

−0.3 (−0.7, 0.1)

0.13

 Glasgow coma scale < 14 (%)

73 (25)

39 (29)

34 (21)

−8.2 (−18.2, 1.8)

0.11

 FAST score (/3)

2 (1)

2 (1)

2 (1)

0.0 (−0.1, 0.2)

0.61

 FAST score = 3 (%)

144 (49)

67 (50)

77 (48)

−2.9 (−14.3, 8.6)

0.63

Hospital admission data (post randomisation)

 Number of patients with data

297

134

163

 

 Ethnic group, non-white (%)

35 (13)

15 (12)

20 (13)

1.2 (−6.7, 9.0)

0.77

 Ethnicity, White (%)

242 (87)

110 (88)

132 (87)

 

 Ethnicity, Black (%)

14 (5)

5 (4)

9 (6)

 Ethnicity, Asian (%)

18 (6)

10 (8)

8 (5)

 Ethnicity, Other (%)

3 (1)

0 (0)

3 (2)

 Pre-morbid mRS [/5]

1 [0,3]

1 [0,3]

0 [0,3]

0.00 (0.00, 0.00)

0.21

 Pre-morbid mRS > 2 (%)

79 (28)

39 (31)

40 (26)

−4.7 (−15.3, 5.9)

0.38

Medical history (%)

 Hypertension

142 (51)

61 (49)

81 (53)

4.1 (−7.8, 15.9)

0.50

 Diabetes mellitus

59 (21)

27 (22)

32 (21)

−0.6 (−10.3, 9.2)

0.91

 Previous stroke

85 (31)

37 (30)

48 (32)

2.2 (−8.7, 13.1)

0.70

 Ischaemic heart disease

58 (21)

29 (24)

29 (19)

−4.2 (−14.1, 5.6)

0.39

 Smoking, current

54 (24)

26 (25)

28 (23)

−2.2 (−13.4, 8.9)

0.69

 Antiplatelets

69 (36)

36 (40)

33 (33)

−7.0 (−20.7, 6.7)

0.32

 Anticoagulants

33 (17)

15 (17)

18 (18)

1.0 (−9.7, 11.7)

0.86

 Either

96 (51)

47 (52)

49 (49)

−3.2 (−17.5, 11.0)

0.66

 OCSP syndrome, TACS (%)

40 (18)

15 (16)

25 (19)

3.6 (−6.4, 13.6)

0.49

 NIHSS (/42)

4 [2,8]

4 [1,9]

4 [2,7]

0.0 (−1.0, 1.0)

0.64

  1. AF atrial fibrillation, bpm beats per minute, ECG electrocardiogram, FAST face-arm-speech test, GTN glyceryl trinitrate, IQR interquartile range, mmHg millimetres of mercury, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, OCSP Oxford Community Stroke Project classification, TACS total anterior circulation stroke. The pre-morbid mRS, as reported by patient or representative, is the functional status of the participant prior to the onset of suspected stroke symptoms